HLA-DQ2 is a well-established genetic risk factor for celiac disease, which can present with skin manifestations such as dermatitis herpetiformis (an intensely itchy, blistering rash). The evidence linking HLA-DQ2 to this skin condition is strong (human-strong). However, a positive genetic test does not diagnose celiac disease or skin disease: only about 3 % of carriers develop celiac, and not all celiac patients have skin involvement. Therefore, the test serves as a risk assessment, not a diagnostic tool. For skin issues like chronic itching or blisters, follow-up with serology (anti-tTG antibodies) and possibly a skin biopsy is necessary. IgG-based food sensitivity panels, as promoted in some combo tests, lack scientific validity for this purpose and may lead to unnecessary dietary restrictions. In summary, HLA-DQ2 testing in the context of skin provides a useful clue but requires medical interpretation. The evidence for the association is robust, but the standalone genetic test has limited clinical utility.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-73ba69f6706ef175fe0d2a67